Search Results - "Arroyo, Concepcion Herrera"
-
1
Significance of Degree of HLA Disparity Using T‐cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT
Published in HemaSphere (01-07-2023)“…Availability of haploidentical donors has broadened utilization of allogeneic hematopoietic cell transplantation (allo‐HCT). Peripheral blood stem cells (PBSC)…”
Get full text
Journal Article -
2
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide‐based Graft Versus Host Disease Prophylaxis
Published in HemaSphere (01-03-2023)“…Graft versus host disease (GVHD) prophylaxis with posttransplantation cyclophosphamide (PTCY) has been established to reduce severe GVHD, and thereby…”
Get full text
Journal Article -
3
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
Published in Bone marrow transplantation (Basingstoke) (01-01-2023)“…Donor lymphocyte infusion (DLI) is a treatment option to prevent or treat relapse after allogeneic hematopoietic cell transplantation (HCT). We here report…”
Get full text
Journal Article -
4
Haploidentical transplant in patients with myelodysplastic syndrome
Published in Blood advances (10-10-2017)“…The only curative treatment in patients with intermediate or high-risk myelodysplastic syndrome (MDS) is allogeneic hematopoietic stem cell transplantation…”
Get full text
Journal Article -
5
Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia
Published in Transfusion (Philadelphia, Pa.) (01-07-2011)“…BACKGROUND: Dendritic cell (DC)‐based immunotherapeutic protocols are being developed to treat acute myeloid leukemia (AML). So far, DCs for clinical use are…”
Get full text
Journal Article -
6
Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients
Published in Journal of gastroenterology and hepatology (01-12-2010)“…Background and Aim: In human blood, two main subsets of antigen‐presenting‐cells (APCs) have been described: plasmocytoid dendritic cells (pDC) and myeloid…”
Get full text
Journal Article -
7
Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT
Published in Bone marrow transplantation (Basingstoke) (18-09-2024)“…Congenital amegakaryocytic thrombocytopenia is a rare, inherited bone marrow failure syndrome. Allogeneic haematopoietic stem cell transplantation (allo-HSCT)…”
Get full text
Journal Article -
8
-
9
Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in First Complete Hematologic Remission (CR1)
Published in Blood (23-11-2021)“…Background: Haploidentical allogeneic hematopoietic cell transplantation (haplo) has expanded applicability of the procedure to patients for whom a suitable…”
Get full text
Journal Article -
10
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT
Published in Bone marrow transplantation (Basingstoke) (01-11-2023)“…In the setting of a first relapse of multiple myeloma (MM), a second autologous stem cell transplant (ASCT) following carfilzomib-lenalidomide-dexamethasone…”
Get full text
Journal Article -
11
Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT
Published in Blood (05-11-2020)“…Introduction Acute and chronic graft vs. host disease (a/cGVHD) are major causes of treatment failure and non-relapse mortality (NRM) in multiple myeloma (MM)…”
Get full text
Journal Article -
12
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study
Published in BLOOD (15-11-2022)Get full text
Journal Article Conference Proceeding -
13
-
14
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Published in Transplantation and cellular therapy (01-12-2021)“…•Post-transplantation cyclophosphamide was studied in patients with multiple myeloma.•A low incidence of graft-versus-host disease was observed.•This approach…”
Get full text
Journal Article -
15
DONOR Lymphocyte Infusions after Haploidentical STEM Cell Transplantation with Ptcy: A Study on Behalf of the Ctiwp of the EBMT
Published in Transplantation and cellular therapy (01-03-2021)Get full text
Journal Article -
16
-
17
Coronary Flow Reserve and Ventricular Function Following Regenerative Treatment in Patients With Revascularized Acute Anterior Myocardial Infarction
Published in Revista española de cardiología (English ed.) (01-05-2018)“…Abstract Introduction and objectives Bone marrow stem cells may reconstruct infarcted myocardium through distinct mechanisms. However, little is known on the…”
Get full text
Journal Article -
18
One Versus 2-stent Strategy for the Treatment of Bifurcation Lesions in the Context of a Coronary Chronic Total Occlusion. A Multicenter Registry
Published in Revista española de cardiología (English ed.) (01-05-2018)“…There is little evidence on the optimal strategy for bifurcation lesions in the context of a coronary chronic total occlusion (CTO). This study compared the…”
Get full text
Journal Article -
19
Reserva coronaria y función ventricular izquierda tras la terapia regenerativa en pacientes con infarto anterior agudo revascularizado
Published in Revista española de cardiologia (01-05-2018)“…Las células madre de médula ósea pueden regenerar el miocardio infartado por distintos mecanismos. La relación entre la recuperación de la función muscular y…”
Get full text
Journal Article